Real-time funding, M&A, exec moves & hiring — the signals that move deals
The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
DARE BIOSCIENCE, INC.
AI Executive Summary
AI-powered analysis of 8-K filing content
Daré Bioscience completed the second closing of its Regulation A offering on March 6, 2026, issuing 17,500 Investor Units at $5.00 per unit for $87,500 in proceeds. This capital raise supports the company's growth initiatives as part of a broader offering of up to 4,854,000 units.
Key Takeaways
Second closing of Reg A offering completed with issuance of 17,500 Investor Units
Each unit comprises one share of Series A Convertible Preferred Stock and two common stock warrants
2 more takeaways